Why The FDA, CDC Pause On Johnson & Johnson Covid-19 Vaccines Makes Sense

Some such as Nate Silver, the founder and editor in chief of FiveThirtyEight, have criticized the pause. But how strong are Silver's arguments?
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news